BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zegallai HM, Hatch GM. Barth syndrome: cardiolipin, cellular pathophysiology, management, and novel therapeutic targets. Mol Cell Biochem 2021;476:1605-29. [PMID: 33415565 DOI: 10.1007/s11010-020-04021-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 da Rosa-junior NT, Parmeggiani B, Glänzel NM, de Moura Alvorcem L, Brondani M, Britto R, Grings M, Ortiz VD, Turck P, da Rosa Araujo AS, Wajner M, Leipnitz G. Antioxidant system disturbances and mitochondrial dysfunction induced by 3-methyglutaric acid in rat heart are prevented by bezafibrate. European Journal of Pharmacology 2022. [DOI: 10.1016/j.ejphar.2022.174950] [Reference Citation Analysis]
2 Fox CA, Moschetti A, Ryan RO. Reconstituted HDL as a therapeutic delivery device. Biochim Biophys Acta Mol Cell Biol Lipids 2021;1866:159025. [PMID: 34375767 DOI: 10.1016/j.bbalip.2021.159025] [Reference Citation Analysis]
3 Loh D, Reiter RJ. Melatonin: Regulation of Biomolecular Condensates in Neurodegenerative Disorders. Antioxidants (Basel) 2021;10:1483. [PMID: 34573116 DOI: 10.3390/antiox10091483] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zegallai HM, Abu-El-Rub E, Olayinka-Adefemi F, Cole LK, Sparagna GC, Marshall AJ, Hatch GM. Tafazzin deficiency in mouse mesenchymal stem cells potentiates their immunosuppression and impairs activated B lymphocyte immune function. bioRxiv 2021:2021. [PMID: 34729562 DOI: 10.1101/2021.09.07.459330] [Reference Citation Analysis]
5 Ralph-Epps T, Onu CJ, Vo L, Schmidtke MW, Le A, Greenberg ML. Studying Lipid-Related Pathophysiology Using the Yeast Model. Front Physiol 2021;12:768411. [PMID: 34777024 DOI: 10.3389/fphys.2021.768411] [Reference Citation Analysis]
6 Fiorucci L, Erba F, Santucci R, Sinibaldi F. Cytochrome c Interaction with Cardiolipin Plays a Key Role in Cell Apoptosis: Implications for Human Diseases. Symmetry 2022;14:767. [DOI: 10.3390/sym14040767] [Reference Citation Analysis]
7 Bradley RM, Hashemi A, Aristizabal-Henao JJ, Stark KD, Duncan RE. PLAAT1 Exhibits Phosphatidylcholine:Monolysocardiolipin Transacylase Activity. Int J Mol Sci 2022;23:6714. [PMID: 35743156 DOI: 10.3390/ijms23126714] [Reference Citation Analysis]
8 Dudek J, Maack C. Mechano-energetic aspects of Barth syndrome. J Inherit Metab Dis 2021. [PMID: 34423473 DOI: 10.1002/jimd.12427] [Reference Citation Analysis]
9 Chaudhuri M, Tripathi A, Gonzalez FS. Diverse Functions of Tim50, a Component of the Mitochondrial Inner Membrane Protein Translocase. Int J Mol Sci 2021;22:7779. [PMID: 34360547 DOI: 10.3390/ijms22157779] [Reference Citation Analysis]
10 Zegallai HM, Abu-El-Rub E, Cole LK, Field J, Mejia EM, Gordon JW, Marshall AJ, Hatch GM. Tafazzin deficiency impairs mitochondrial metabolism and function of lipopolysaccharide activated B lymphocytes in mice. FASEB J 2021;35:e22023. [PMID: 34767647 DOI: 10.1096/fj.202100811RR] [Reference Citation Analysis]
11 Bozelli JC Jr, Epand RM. Interplay between cardiolipin and plasmalogens in Barth syndrome. J Inherit Metab Dis 2021. [PMID: 34655242 DOI: 10.1002/jimd.12449] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Yang Z, Wang L, Yang C, Pu S, Guo Z, Wu Q, Zhou Z, Zhao H. Mitochondrial Membrane Remodeling. Front Bioeng Biotechnol 2021;9:786806. [PMID: 35059386 DOI: 10.3389/fbioe.2021.786806] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Braschi B, Seal RL, Tweedie S, Jones TEM, Bruford EA. The risks of using unapproved gene symbols. Am J Hum Genet 2021;108:1813-6. [PMID: 34626580 DOI: 10.1016/j.ajhg.2021.09.004] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Zegallai HM, Abu-El-Rub E, Olayinka-Adefemi F, Cole LK, Sparagna GC, Marshall AJ, Hatch GM. Tafazzin deficiency in mouse mesenchymal stem cells promote reprogramming of activated B lymphocytes toward immunosuppressive phenotypes. FASEB J 2022;36:e22443. [PMID: 35816277 DOI: 10.1096/fj.202200145R] [Reference Citation Analysis]
15 Serricchio M, Bütikofer P. A Conserved Mitochondrial Chaperone-Protease Complex Involved in Protein Homeostasis. Front Mol Biosci 2021;8:767088. [PMID: 34859054 DOI: 10.3389/fmolb.2021.767088] [Reference Citation Analysis]
16 Thompson R, Jefferies J, Wang S, Pu WT, Takemoto C, Hornby B, Heyman A, Chin MT, Vernon HJ. Current and future treatment approaches for Barth syndrome. J Inherit Metab Dis 2021. [PMID: 34713454 DOI: 10.1002/jimd.12453] [Reference Citation Analysis]
17 Bargui R, Solgadi A, Prost B, Chester M, Ferreiro A, Piquereau J, Moulin M. Phospholipids: Identification and Implication in Muscle Pathophysiology. Int J Mol Sci 2021;22:8176. [PMID: 34360941 DOI: 10.3390/ijms22158176] [Reference Citation Analysis]
18 Zegallai HM, Hatch GM. Impaired surface marker expression in stimulated Epstein-Barr virus transformed lymphoblasts from Barth Syndrome patients. Sci Rep 2022;12:6195. [PMID: 35418665 DOI: 10.1038/s41598-022-10270-4] [Reference Citation Analysis]
19 Elkes M, Andonovski M, Vidal D, Farago M, Modafferi R, Claypool SM, LeBlanc PJ. The Influence of Supplemental Dietary Linoleic Acid on Skeletal Muscle Contractile Function in a Rodent Model of Barth Syndrome. Front Physiol 2021;12:731961. [PMID: 34489741 DOI: 10.3389/fphys.2021.731961] [Reference Citation Analysis]